August 18, 2025

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 4.24% Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS), a leader in the Health Information Services industry, has caught the attention of investors with its compelling growth metrics and a promising outlook. The San Francisco-based..

Insulet Corporation (PODD) Stock Analysis: Revenue Growth and Analyst Ratings Signal Promising Future

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) to be a compelling prospect, thanks to its innovative advances in insulin delivery systems and..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and a Promising 12.53% Upside

For investors with an eye on the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) presents an intriguing opportunity. With a market capitalization of $184.66 billion, this United States-based leader..

Medtronic plc (MDT) Stock Analysis: A Healthcare Giant with 4.62% Potential Upside

Medtronic plc (NYSE: MDT), a titan in the medical devices sector, continues to be a compelling choice for investors seeking stability and growth in the healthcare industry. With its global..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a Strong Buy Consensus with 8.45% Potential Upside

For individual investors eyeing opportunities in the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents a compelling case. As a leader in Diagnostics & Research, Labcorp not only offers a..

Mettler-Toledo International (MTD) Stock Analysis: Evaluating the 3.90% Revenue Growth and Analyst Ratings

Mettler-Toledo International Inc. (NYSE: MTD), a stalwart in the diagnostics and research industry, continues to capture investor attention with its robust market presence and consistent revenue growth. As a leader..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a 30.21% Return on Equity Amidst Healthcare Sector Dynamics

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, stands as a formidable entity in the drug manufacturing industry, boasting a market capitalization of $425.41 billion. With operations..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 27% Upside Potential

For investors looking to delve into the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling opportunity, particularly with a potential upside of 27.31%. Headquartered in San Ramon,..

Solventum Corporation (SOLV): Investor Outlook with a 21.41% Upside Potential

Solventum Corporation (NYSE: SOLV), a key player in the healthcare sector, has been gaining attention for its diverse portfolio of solutions that cater to critical customer and patient needs. With..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking a 31.65% Potential Upside for Investors

Summit Therapeutics Inc. (NASDAQ: SMMT) is a name that has increasingly caught the attention of investors within the biotechnology sector. With its robust market capitalization of $19.83 billion, this Miami-based..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and a 14.83% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player in the U.S. healthcare sector, primarily operating within the medical care facilities industry. With a substantial market capitalization of $15.2..

Cencora, Inc. (COR) Stock Analysis: 13.82% Potential Upside and Strong Buy Ratings Fuel Investor Interest

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, presents a compelling opportunity for investors looking to tap into the robust healthcare sector. With a market capitalization of $56.77 billion,..

Natera, Inc. (NTRA): Investor Outlook on a Diagnostics Leader with a 21.33% Potential Upside

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry, offers a compelling investment opportunity for those eyeing the healthcare sector. With a market capitalization of $22.37..

The Cigna Group (CI) Stock Analysis: Exploring a 23.92% Upside Potential for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, presents an intriguing prospect for individual investors, with analysts predicting a potential upside of nearly 24%. This article delves..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Insights into a Healthcare Giant with 11.49% Potential Upside

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth indicators. With a market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: Is This Swiss Biotech Giant Worth Your Investment?

For investors eyeing the biotechnology sector, BeOne Medicines Ltd. (ONC) emerges as a compelling opportunity, boasting a substantial market cap of $38.83 billion. This Swiss-based oncology company is at the..

BioNTech SE (BNTX) Stock Analysis: 21% Potential Upside Amid Strong Buy Consensus

BioNTech SE, a prominent player in the biotechnology sector, has been a focal point for investors due to its pioneering work in immunotherapies for cancer and infectious diseases. Headquartered in..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 19% Potential Upside in Biopharmaceutical Royalties

Investors looking for exposure in the biopharmaceutical sector might find Royalty Pharma plc (NASDAQ: RPRX) an intriguing option, particularly with the potential for a 19.08% upside. This New York-based company,..

AstraZeneca PLC (AZN) Investor Outlook: Analyzing Growth Potential with a 9.40% Upside

AstraZeneca PLC (AZN), a titan in the healthcare sector, is renowned for its robust portfolio of prescription medicines that cater to a broad spectrum of medical needs. From oncology to..

Cardinal Health, Inc. (CAH): Investor Outlook on Strong Analyst Buy Ratings with 20.62% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of $35.73 billion, Cardinal Health..

Search

Funds

August 18, 2025

Search

Funds

August 18, 2025

FTSE 100

Funds